The protocol may be adjusted for skin tone-specific considerations at the APRN intake evaluation
however, their clinical validation doesn't match that of injections like Zepbound
Men with serious cardiovascular disease such as uncontrolled high blood pressure, recent heart attack, heart failure, or unstable chest pain should not start peptide therapy without medical clearance
Staying hydrated, eating smaller frequent meals, and avoiding high-fat foods reduces severity
Expected Weight Loss: In the head-to-head SURMOUNT-5 trial published in The New England Journal of Medicine , tirzepatide was shown to be superior to semaglutide for reduction in body weight and waist circumference at 72 weeks among adults with obesity (without diabetes)
Make sure the needle is in the liquid medicine